Hardik Parikh
Stock Analyst at JP Morgan
(n/a)
# 4,916
Out of 5,240 analysts
7
Total ratings
n/a
Success rate
-46.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KLRA Kailera Therapeutics | Initiates: Overweight | $30 | $21.61 | +38.82% | 1 | May 12, 2026 | |
| GPCR Structure Therapeutics | Maintains: Overweight | $65 → $105 | $37.97 | +176.57% | 2 | Jan 22, 2026 | |
| VKTX Viking Therapeutics | Maintains: Overweight | $80 → $75 | $31.47 | +138.32% | 2 | Oct 24, 2025 | |
| PCRX Pacira BioSciences | Downgrades: Underweight | $45 → $10 | $23.31 | -57.10% | 2 | Aug 12, 2024 |
Kailera Therapeutics
May 12, 2026
Initiates: Overweight
Price Target: $30
Current: $21.61
Upside: +38.82%
Structure Therapeutics
Jan 22, 2026
Maintains: Overweight
Price Target: $65 → $105
Current: $37.97
Upside: +176.57%
Viking Therapeutics
Oct 24, 2025
Maintains: Overweight
Price Target: $80 → $75
Current: $31.47
Upside: +138.32%
Pacira BioSciences
Aug 12, 2024
Downgrades: Underweight
Price Target: $45 → $10
Current: $23.31
Upside: -57.10%